Conversely, Patel et al. recently reported targeted sequencing data from 109 patients with NPM1-mutated AML to retrospectively evaluate the potential significance of NPM1 variant allele frequency (VAF) at diagnosis, comutations and clinical features on patient outcomes [76]. The gene discussed is NPM1; the disease is acute myeloid leukemia.